Abstracts of Roma Pain Days 2023
1Congress Organization, Paolo Procacci Foundation, Rome, Italy
DOI: 10.22514/sv.2023.040 Vol.19,Issue 4,July 2023 pp.223-262
Submitted: 04 May 2023 Accepted: 29 May 2023
Published: 08 July 2023
The third edition of the Roma Pain Days (#RPD23) has shown the great interest existing on pain medicine and on education in this difficult, challenging part of the every day clinical practice. As anyone may observe, the scientific program has expanded its interests. This is also the case with the number of abstract submitted. It is significantly increased, compared to last year.
The #RPD23 is still an “hybrid” congress, and again the Scientific Committee has tried to collect and diffuse much more the results of the many, many researchers willing to present their results to the large public. Also this year the abstracts are published on Signa Vitae, an indexed open access journal (https://www.signavitae.com). All the accepted abstracts will be published immediately before the congress visible and downloadable in the website. Signa Vitae is a growing and thrilling journal whose impact in the scientific world interested in Anesthesiology, Emergency, Intensive Care, and Pain Medicine is already well established. The Scientific Committee of the #RPD23 thank the General Management of the journal for their kindness and generosity. We are more than sure that this will be of a mutual benefit for the researchers and the journal’s visibility. Ad maiora for a future, increasing cooperation in favor of the science diffusion, and of the Pain Medicine.
Giustino Varrassi. Abstracts of Roma Pain Days 2023. Signa Vitae. 2023. 19(4);223-262.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.